ImmunityBio Simulations give clue to why South African strain of SARS-CoV-2 is rapidly spreading EP News Bureau Jan 19, 2021 Using Molecular Dynamic (MD) simulation, ImmunityBio scientists assessed the affinity of mutated spike receptor-binding domain…
ImmunityBio and NantKwest announce merger EP News Bureau Dec 21, 2020 Merged entity brings together 11 Phase II / III clinical trials across oncology and infectious disease that use combined…
ImmunityBio COVID-19 vaccine candidate shows protection of airways in non-human primates EP News Bureau Dec 11, 2020 The hAd5-COVID-19 candidate is designed to address a potential problem that may emerge when first-generation adenoviral platforms…
ImmunityBio, NantKwest begin patient dosing in Phase 1 clinical trial of COVID-19 vaccine candidate EP News Bureau Oct 22, 2020 The Phase 1 trial, being conducted at the Hoag Hospital in Newport Beach, California, is enrolling healthy adult subjects up to…
US FDA authorises phase 1 trial of ImmunityBio’s COVID-19 vaccine candidate hAd5 EP News Bureau Oct 15, 2020 Ongoing development proceeding for oral, inhalational and intranasal administration of hAd5